T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$4.06B |
| 2 |
Oracle
ORCL
|
+$2.93B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.35B |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.44B |
| 2 |
Eli Lilly
LLY
|
+$2.51B |
| 3 |
Microsoft
MSFT
|
+$2.39B |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.3% |
| 2 | Financials | 11.67% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
Larimar Therapeutics
LRMR
$445M
| $75K | ﹤0.01% |
22,970
+1,669
| +8% | +$6.26K |
|
2952
Evolution Petroleum
EPM
$135M
| $74K | ﹤0.01% |
15,280
| – | – |
|
2953
Hain Celestial
HAIN
$53.8M
| $74K | ﹤0.01% |
46,439
-52,760
| -53% | -$89.9K |
|
|
FSP
2954
Franklin Street Properties
FSP
$46.7M
| $73K | ﹤0.01% |
45,600
-72,826
| -61% | -$121K |
|
2955
Veru
VERU
$45.4M
| $73K | ﹤0.01% |
19,011
-1
| -0% | -$4 |
|
2956
Karyopharm Therapeutics
KPTI
$44.4M
| $72K | ﹤0.01% |
10,886
| – | – |
|
2957
Sight Sciences
SGHT
$463M
| $72K | ﹤0.01% |
20,785
+1,778
| +9% | +$6.62K |
|
2958
Protara Therapeutics
TARA
$232M
| $72K | ﹤0.01% |
16,353
| – | – |
|
2959
Kaltura
KLTR
$243M
| $70K | ﹤0.01% |
47,957
| – | – |
|
|
BIOA
2960
BioAge Labs
BIOA
$487M
| $70K | ﹤0.01% |
+11,891
| New | +$55.7K |
|
2961
Fate Therapeutics
FATE
$310M
| $69K | ﹤0.01% |
54,470
+7,615
| +16% | +$8.21K |
|
2962
Montauk Renewables
MNTK
$268M
| $69K | ﹤0.01% |
33,876
-38,000
| -53% | -$81.4K |
|
|
NXDT
2963
NexPoint Diversified Real Estate Trust
NXDT
$262M
| $69K | ﹤0.01% |
18,473
+666
| +4% | +$2.83K |
|
2964
Outdoor Holding Co
POWW
$261M
| $68K | ﹤0.01% |
45,440
| – | – |
|
2965
Commercial Vehicle Group
CVGI
$130M
| $66K | ﹤0.01% |
38,483
-60,800
| -61% | -$111K |
|
2966
Rackspace Technology
RXT
$1.07B
| $66K | ﹤0.01% |
46,112
+9,653
| +26% | +$12.9K |
|
2967
Cardiff Oncology
CRDF
$79.4M
| $65K | ﹤0.01% |
31,330
+1,187
| +4% | +$3.28K |
|
2968
DocGo
DCGO
$64.2M
| $64K | ﹤0.01% |
46,937
-34,100
| -42% | -$51.6K |
|
2969
Vera Bradley
VRA
$94.1M
| $64K | ﹤0.01% |
31,474
-35,500
| -53% | -$75.2K |
|
2970
Acacia Research
ACTG
$453M
| $61K | ﹤0.01% |
18,738
| – | – |
|
|
EWCZ
2971
DELISTED
European Wax Center
EWCZ
| $61K | ﹤0.01% |
15,255
| – | – |
|
2972
Phunware
PHUN
$43.4M
| $61K | ﹤0.01% |
+22,072
| New | +$63.5K |
|
2973
1-800-Flowers.com
FLWS
$260M
| $60K | ﹤0.01% |
12,849
| – | – |
|
2974
InnovAge Holding
INNV
$1.45B
| $60K | ﹤0.01% |
11,499
+577
| +5% | +$2.33K |
|
2975
Nkarta
NKTX
$170M
| $60K | ﹤0.01% |
28,922
+3,726
| +15% | +$7.65K |
|
Similar funds
T. Rowe Price Associates's Q3 2025 Portfolio in Review
As of Q3 2025, T. Rowe Price Associates held 3,142 positions worth $935B, up 5.9% from $883B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q3 2025 filing shows 87 new, 2,049 increased, 682 reduced and 98 closed positions. Its largest new stake was Cemex: 19,009,088 shares worth $171M. The largest sale was Amazon, an estimated $3.44B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2025 buy was Cemex: 19,009,088 shares worth $171M.
- T. Rowe Price Associates added most to Arista Networks in Q3 2025, an estimated $4.06B increase.
- T. Rowe Price Associates's biggest Q3 2025 reduction was Amazon, cutting an estimated $3.44B.
- T. Rowe Price Associates fully exited Hess in Q3 2025, selling an estimated $308M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $935B portfolio in Q3 2025.
- T. Rowe Price Associates opened 87 new positions and closed 98 in Q3 2025.
- T. Rowe Price Associates's portfolio value rose 5.9% quarter-over-quarter to $935B.
Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.